Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Anti-AIDS Drug Becomes Ten Times Less Toxic

17.06.2005


Outstanding antiviral action of multiple antibiotics remains unclaimed due to high drug toxicity. Russian physicians are trying to get nontoxic drug dosage form and have achieved success as regards to anit-AIDS antibiotic – Heliomycinum. Their effort has been funded by the International Science and Technology Center.



Specialists of the Lomonosov Moscow State Academy of Fine Applied Chemistry and Ivanovsky Scientific Research Institute of Virology (Russian Academy of Medical Sciences) have found the way to reduce by ten times toxicity of anit-AIDS antibiotic Heliomycinum (Resistomycinum). To this end, antibiotic was enclosed into an adipose (lipidic) bubble - liposome.

Utilization of liposomes as a carrier of drugs is increasingly attracts attention of researchers. Liposomes are non-toxic and get fully decomposed in the organism. As lipids’ disintegration occurs gradually, the drug enclosed in liposome is also released in small doses, thus allowing to create drugs with durable action and to reduce their toxicity.


Heliomycinum is one of the drugs whose toxicity the researchers are eager to reduce. This antibiotic blocks the action of several specific enzymes of human immunodeficiency virus, therefore, it has been considered a promising antiviral drug for a long time. However, Heliomycinum has not been widely accepted in medicine due to very poor solubility in water and high toxicity. Heliomycinum inclusion into liposomes would improve the drug quality and allow to create its injection form of low toxicity.

To obtain a liposomic drug, the researchers added the Heliomycinum solution in the chloroform and methanol mixture to the lipidic film. Samples were frozen in liquid nitrogen and stirred up at room temperature. The freezing/thawing cycle was repeated for five more times. As a result, antibiotic embedded into the lipidic film. Then, the mixture was forced through the filters with small interstices to separate non-bound Heliomycinum, and the medicinal mixture itself was smashed to small bubbles containing known concentration of antibiotic. The researchers sorted out such lipid composition that up to 97 percent of Heliomycinum is included into liposomes. Having hidden Heliomycinum into liposomes, the researchers succeeded to dissolve it in physiological solution, which is important for pharmaceutical purposes.

The liposome drug toxicity was tried on the culture of embryonic fibroblasts. Heliomycinum in aqueous solution destroyed every single cell already within 24 hours, and toxicity of liposomic form turned out to be ten times lower. Antiviral activity of liposomic Heliomycinum was tried on the culture of fibroblasts which were infected by cytomegalovirus. This human virus does not cause diseases and ideally fits for model experiments. A new drug has turned out to be active against virus, the drug being applied in such concentration that it is non-toxic for cells.

Sergey Komarov | alfa
Further information:
http://www.informnauka.ru

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>